title: [New treatment option for patient with CML-bosutinib].
authors.forename: Naoto
authors.initials: N
authors.lastname: Takahashi
mesh_terms: D000814:Aniline Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics; D058990:Molecular Targeted Therapy; D009570:Nitriles / Q000009:adverse effects / Q000627:therapeutic use*; D017354:Point Mutation; D011804:Quinolines / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000814:Aniline Compounds; D009570:Nitriles; D011804:Quinolines; C471992:bosutinib; D016044:Fusion Proteins, bcr-abl